Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Intestinal Diseases

• Fluorescence Imaging of Adalimumab-680LT in Inflammatory Bowel Disease
• Neuromuscular Blockade Comparison for GI-2 Recovery After Bowel Resection
• Xylitol Use for Decolonization of C. Difficile in Patients With IBD
• Clinical Study of Vitamin B5 in Adjuvant Treatment of IBD
• Feasibility, Safety, and Potential Efficacy of Fecal Microbiota Transplantation (FMT) for Gastrointestinal Dysfunction in Children Following Hematopoietic Cell Transplant (HCT).
• A Phase 2b Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC
• Pre-treatment With Azithromycin to Reduce Immunogenicity to Anti-Tumor Necrosis Factor-α Agents in Patients With Inflammatory Bowel Disease
• High Dose Steroid to Treat Flares in Inflammatory Bowel Disease
• Stem Cells for the Treatment of Pouchitis
• Clinical Study Evaluating the Gastroprotective Effect of Carvedilol in Patients With Ischemic Heart Disease on Aspirin Therapy
• Effectiveness of Fecal Microbiota Transplantation as add-on Therapy in Mild-to-moderate Ulcerative Colitis
• A Prospective Study of the Effect of Modified Colonoscopy Bowel Preparation Program on Intestinal Cleaning, Examination and Disease in Patients With Inflammatory Bowel Disease
• Camostat Mesylate for Protein-losing Enteropathy After Fontan Operation
• A Study to Evaluate LB1148 for Return of Bowel Function in Subjects Undergoing Bowel Resection
• Predicting Response to Iron Supplementation in Patients With Inflammatory Bowel Disease During Induction Therapy
• Bladder and Bowel Dysfunction in Children
• A Phase 2a Open-Label Study to Evaluate the Efficacy and Safety of MORF-057 in Adults With UC
• Infliximab and Adalimumab in Irritable Bowel Disease Patients.
• Early Proactive Therapeutic Drug Monitoring of Infliximab in Children: EPIC Study
• Comparison for Efficacy and Safety of Bowel Preparation Between Oral Sulfate Table and 2L-polyethylene Glycol/Ascorbate in Elderly
• Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy
• Investigating the Anti-inflammatory Effects of Frondanol in Adults With Inflammatory Bowel Disease
• Efficacy and Safety of Mebeverine + Simethicone in Patients With Functional Bowel Disorders
• Response To Medical Therapy in Inflammatory Bowel Disease Patients Carrying-out a Prescribed Exercise Programme
• Cholecalciferol Comedication in IBD - the 5C Study
• Model-informed Dose De-escalation of Infliximab in Patients With Inflammatory Bowel Diseases
• The MIRO II Study: Microbial Restoration in Inflammatory Bowel Diseases
• Efficacy and Safety of Vedolizumab in Biologic-naïve Korean Patients With Moderate to Severe Inflammatory Bowel Disease
• Vitamin D Regulation of Gut Specific B Cells and Antibodies Targeting Gut Bacteria in Inflammatory Bowel Disease
• Brentuximab Vedotin and Pembrolizumab in Treating Patients With Recurrent Peripheral T-Cell Lymphoma
• SGM-101 in Colorectal Brain Metastases.
• A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors
• Single Dose Bioavailability and Ethnobridging PK Study in Healthy Subjects
• Clinical Burden of Anemia in Inflammatory Bowel Disease: Therapeutic Trial
• Sugammadex To IMprove Bowel Function
• A Multicenter Clinical Trial: Efficacy, Safety of Fecal Microbiota Transplantation for Inflammatory Bowel Disease
• Stablishment of Prevention and Treatment System for Intestinal Dysfunction
• Characterizing Inflammatory Bowel Disease With 68Ga-FAPI PET/CT
• Correlation of Serum Adalimumab Levels at an Administration of 40 mg Weekly vs 80 mg Every Two Weeks
• Chronotherapy in Inflammatory Bowel Disease
• Effect of Palatable Lidocaine Gel on Gag Reflex for Patients Undergoing Upper Gastrointestinal Endoscopy
• Open-Label Efficacy and Safety Study of Pozelimab in Patients With CD55-Deficient Protein-Losing Enteropathy (CHAPLE Disease)
• Study of NPO-13 During Colonoscopy
• Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients
• Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative Colitis
• Prevention of Radiotherapy Induced Enteropathy by Probiotics (PREP)
• Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2831781 After an Intravenous (IV) Dose in Healthy Japanese and Caucasian Subjects, and a Subcutaneous (SC) Dose in Healthy Caucasian Subjects
• Rifaximin and Misoprostol Combination Therapy for Healing of Small Bowel Ulcers in Aspirin Users
• Postoperative Extended Venous Thromboprophylaxis in Inflammatory Bowel Disease
• Budesonide in Patients With Immune Mediated Enteropathies
• Folic Acid in Pediatric Inflammatory Bowel Disease
• Mode of Action of Ondansetron, a 5-HT Receptor 3 Antagonist, in Lactulose Induced Diarrhoea
• ICON-2: FMT and Bezlotoxumab Compared to FMT and Placebo for Patients With IBD and CDI
• Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®)
• Therapeutic Approaches to Malnutrition Enteropathy
• Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas
• Food-effect, Drug-Drug Interaction (DDI), and Formulation Bridging Study
• Diagnostic Validity of [18F]FSPG PET for the Assessment of Disease Activity in Inflammatory Bowel Disease
• Safety and Efficacy of PBK-1701TC for Bowel Cleansing Before Colonoscopy
• A Trial Comparing the Incidence of Hypophosphatemia in Relation to Treatment With Iron Isomaltoside and Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia Due to Inflammatory Bowel Disease
• Perioperative Dexamethasone on Postoperative Outcome in IBD
• Nabilone Use For Acute Pain in Inflammatory Bowel Disease Patients
• TD-1473 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects
• Evaluation of the Clinical and Immunological Impact of Two Therapeutic Strategies in Chronic Inflammatory Diseases
• GSK2983559 First Time in Human Study
• Preoperative Oral ImmunoNuTrition to Improve Surgical Outcomes for IBD Patients (PINT)
• NEOadjuvant Chemotherapy Only Compared With Standard Treatment for Locally Advanced Rectal Cancer
• Stricture Definition and Treatment (STRIDENT) Drug Therapy Study
• CHP-BV Followed by Consolidation With High-dose Therapy / ASCT as Frontline Treatment of Patients With EATL Type 1.
• Study to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Inflammatory Bowel Disease
• Efficacy and Safety of Etrasimod (APD334) in Inflammatory Bowel Disease Patients With Active Skin Extra-intestinal Manifestations
• Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma
• The ICON Study: Outcomes After FMT for Patients With IBD and CDI
• T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas
• Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors
• Lanreotide in the Treatment of Small Bowel Motility Disorders
• GIS-SUSANTI-TNF-2015 (Anti-TNF Discontinuation )
• Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases
• Prucalopride Prior to Small Bowel Capsule Endoscopy
• Trial of Captafer® vs. Oral Iron Sulfate in the Treatment of Iron Deficiency Anemia in Patients With IBD
• Anemia in Inflammatory Bowel Disease
• Early Biomarkers in Circulating α 4β7 + T Cells to Predict Response to Vedolizumab in Inflamatory Bowel Disease Patients.
• Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
• Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis
• A Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (<10%) Mature T Cell Lymphoma (TCL)
• Opioid Induced Bowel Dysfunction in Patients Undergoing Spinal Surgery
• Opioid Induced Bowel Dysfunction in Patients Undergoing Cesarean Section
• An Efficacy and Safety Study of Infliximab Dose Escalation in Pediatric Participants With Inflammatory Bowel Disease
• Combination Chemotherapy and Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma
• Influence of Fish Oil Based Intravenous Fat Emulsions on the Epidermal Barrier Function
• Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease
• CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL
• TOPIT; Trough Level Optimized Pediatric Inflammatory Bowel Disease Therapy: A Multicenter Study Comparing Effectiveness of Trough Level Optimized Infliximab Maintenance Therapy With Standard Dosing Regimen of Pediatric Patients With Crohn's Disease
• Effects of Exclusive Enteral Nutrition on the Microbiome in Pediatric Inflammatory Bowel Disease
• Iron Supplementation in Inflammatory Bowel Disease (IBD) Patients With Chronic Fatigue
• Trial Evaluating Chemoprophylaxis Against Travelers' Diarrhea - Prevent TD
• The Best Dosage and Timing of Polyethylene Glycol for Bowel Preparation Before Capsule Endoscopy
• Therapeutic Modulation of the Intestinal Creatine Kinase System in Inflammatory Bowel Disease (IBD)
• Fecal Microbiota Transplant for Inflammatory Bowel Disease
• Precision Dosing of Infliximab Versus Conventional Dosing of Infliximab
• "Efficacy and Safety of Infliximab-biosimilar (Inflectra) Compared to Infliximab-innovator (Remicade) in Patients With Inflammatory Bowel Disease in Remission: the SIMILAR Trial"
• Study to Evaluate the Pharmacokinetics of Fidaxomicin in Inflammatory Bowel Disease (IBD) Subjects With Clostridium Difficile Infection (CDI)
• A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
• Standardized Fecal Microbiota Transplantation for Inflammatory Bowel Disease
• High Volume Simethicone VCE Clinical Trial
• Thiopurine Induced Pancreatitis in IBD Patients
• Phase Ⅱ Dose Response Study of NPO-13 in Patients Undergoing Total Colonoscopy
• Combined Package of Interventions for Environmental Enteropathy
• Low Volume Colon Preparation for IBD
• Thrombolysis in Ischemic Spinal Cord Stroke
• Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease
• Treatment Response of Injectafer vs Oral Iron to Baseline Hepcidin Levels in Patients With Iron Deficiency Anemia (IDA) Secondary to Inflammatory Bowel Disease (IBD) or Gastric Bypass
• Anti-TNF-alpha Trough Level Measurements in Inflammatory Bowel Disease
• Efficacy and Safety Study of Tripterygium Glycoside in the Treatment of Crohn's Disease for Induction Remission
• Treatment of Iron Deficiency Anaemia in Inflammatory Bowel Disease With Ferrous Sulphate
• Steroid-induced Mood Changes in Patients With Inflammatory Bowel Disease
• Anti Tumor Necrosis Factor Alpha Agents and Surgical Stress Response
• Effects of Fish Oil and Colesevelam (STAIR7007)
• Satisfaction With Nurse Administered Propofol Sedation vs. Midazolam With Fentanyl Sedation for Endoscopy
• Efficacy of Buscopan® in Comparison With 654-II (Anisodamine) in Acute Gastric or Intestinal Pain
• Effect of TU-100 in Patients With Irritable Bowel Syndrome (IBS)
• Mesalamine in Environmental Enteropathy
• Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease
• Safety and Treatment Effect of QBECO in Moderate to Severe Crohn's Disease
• Standardized Fecal Microbiota Transplantation for Crohn&Apos;s Diseases
• Standardized Fecal Microbiota Transplantation for Ulcerative Colitis
• The Effect of Probiotics on Exacerbation of Inflammatory Bowel Disease Exacerbation (Crohn's Disease)
• Postpartum Deworming: Improving Breastfeeding and Optimizing Infant Growth
• CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of MT-1303 in Subjects With Inflammatory Bowel Disease
• Vitamin D Treatment in Ulcerative Colitis
• Iron Isomaltoside 1000 (Monofer®) Administered by a High Dosing Regimen in Subjects With Inflammatory Bowel Disease
• Effectiveness of Micronutrient Supplementation and Fish Oil + Micronutrient Supplementation in the Treatment of Environmental Enteropathy
• Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell Lymphoma
• Sitosterolemia Metabolism
• Study of Repetitive Intestinal Lavage in Patients With EHEC Associated Hemorrhagic Colitis
• Gut Microbial Transplantation in Pediatric Inflammatory Bowel Diseases
• Effectiveness of High-dose Zinc Therapy and Albendazole in the Treatment of Environmental Enteropathy
• IV Iron Sucrose vs Oral FeSO4 in Treating IDA in Pediatric IBD
• Comparison of Ferrisat vs Placebo in Anemia Associated to Inflammatory Bowel Disease During Anti-TNF Therapy
• Safety and Efficacy Extension Study of Iron Isomaltoside 1000 (Monofer®) in Subjects With Inflammatory Bowel Disease
• Safety and Tolerability of Crofelemer for HIV-Associated Diarrhea
• Methylnaltrexone in Patients With Opioid-Induced Bowel Dysfunction
• Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Crohn's Disease (AEGIS-2)
• Safety of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease (IBD)
• Rifaximin and Placebo in the Treatment of Bowel Dysfunction After Anterior Resection for Rectal Cancer
• Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1)
• The Effect of a Deworming Intervention to Improve Early Childhood Growth and Development in Resource-poor Areas
• Opioid-induced Bowel Dysfunction (OBD) Pivotal Assessment of Lubiprostone (OPAL)
• Trial for Quantity-Effect Relationship of Acupuncture With Two-ways Regulation to Treat Functional Enteropathy
• Lactated Ringer's Solution in Neonates With Feeding Intolerance
• A Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study of E6007 in Healthy Subjects
• Open-label PK Study of Iron Isomaltoside 1000 (Monofer) Administered by 500 mg IV Injection or 1000 mg IV Infusion to Patients With Inflammatory Bowel Disease
• Efficacy of Albendazole to Treat Intestinal Helminths and Its Effect on Gut Microflora
• Pilot/Ph I Safety and Efficacy of ODSH in Protein Losing Enteropathy Secondary to Single Ventricle Palliative Surgery
• Study to Evaluate the Safety and Efficacy of Naldemedine (S-297995) for the Treatment of Opioid-Induced Bowel Dysfunction in Subjects With Chronic Pain
• A Trial of Iron Replacement in Patients With Iron Deficiency.
• Bowel Function After Minimally Invasive Urogynecologic Surgery
• Cannabis for Inflammatory Bowel Disease
• Cannabidiol for Inflammatory Bowel Disease
• Efficacy Safety Study of Flu Vaccine in Immunodepression Patients
• Iron Oligosaccharide in Inflammatory Bowel Disease Subjects With Iron Deficiency Anaemia
• An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn's Disease
• Saccharomyces Cerevisiae CNCM I-3856 Treatment in Irritable Bowel Syndrome With Diarrhea (IBS-D) and Post Infective Bowel Dysfunction
• Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell Lymphoma
• Curcumin in Pediatric Inflammatory Bowel Disease
• Ferinject® in Patient With Thrombocytosis Secondary to Inflammatory Bowel Disease (IBD)
• Trial of Rifaximin in the Treatment of Tropical Enteropathy
• Azathioprine & Allopurinol in Inflammatory Bowel Disease Patients
• SC12267 (4SC-101) for Treatment of Patients With Inflammatory Bowel Disease
• FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR
• Maintenance Treatment of Iron Deficiency in IBD Patients
• The Use of Oral Budesonide and Rectal Hydrocortisone for the Treatment of Active Ulcerative Colitis
• Can SMOFlipid®, A Composite Parenteral Nutrition Lipid Emulsion, Prevent Progression Of Parenteral Nutrition Associated Liver Disease In Infants?
• Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease
• Thalidomide in Pediatric Inflammatory Bowel Diseases.
• Study of MLN8237 in Participants With Advanced Hematological Malignancies
• Comparison of Small Bowel Lesions Associated With Celecoxib Versus Ibuprofen Plus Omeprazole
• Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
• Open Label Seroquel (Quetiapine) Study for Treatment Resistant Functional Bowel Disorder
• A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease
• Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone
• Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
• Cost-effectiveness of TPMT Pharmacogenetics
• Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
• Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative Colitis
• Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/ Postoperative Ileus
• Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus
• Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus
• Study Evaluating IV Methylnaltrexone for the Treatment of Post Operative Ileus
• Study Evaluating Oral MOA-728 for the Treatment of Opioid-Induced Bowel Dysfunction (OIBD) in Subjects With Chronic Non-Malignant Pain
• Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease
• Safety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With Fistulas
• Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
• Cyclophosphamide in Treating Young Patients With Severe Autoimmune Enteropathy
• Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
• Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
• MICI-CMV:Valganciclovir in Recurrent Bouts of Cryptogenic Inflammatory Bowel Diseases With an Infection by Cytomegalovirus
• Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind, Placebo Controlled Efficacy and Safety Study
• Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus
• The Influence of 5-Aminosalicylates on Thiopurine Metabolite Levels
• Dexamethasone Versus Methylprednisolone for the Treatment of Active Inflammatory Bowel Disease
• Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
• Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
• Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative Colitis
• A Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn's Disease
• A Pharmacokinetic Study to Determine the Oral Bioavailability of Methotrexate in Patients With Inflammatory Bowel Disease
• Treatment of Functional Bowel Disorders